Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Br J Dermatol ; 167(1): 29-35, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22348338

RESUMEN

BACKGROUND: Leprosy is complicated by immunological reactions which can occur before, during and after successful completion of multidrug therapy. Genetic studies have suggested that polymorphisms in toll-like receptors (TLRs) may affect the susceptibility of an individual with leprosy to developing Type 1 reactions. OBJECTIVES: To examine the gene and protein expression of TLRs in the cutaneous lesions of leprosy Type 1 reactions at the onset of reaction and during systemic corticosteroid therapy. METHODS: Patients who were being treated for leprosy type 1 reactions with corticosteroids as part of a randomized controlled trial of corticosteroid treatment had skin biopsies performed before, during and at the end of treatment. The gene and protein expression of TLR2 and TLR4 were measured. RESULTS: We have demonstrated that the gene hARP-P0 is a suitable control gene for TLR gene expression studies in this population. The gene and protein expression of TLR2 and TLR4 were both reduced significantly during corticosteroid treatment. CONCLUSIONS: This is the first study to examine the expression of TLR2 and TLR4 in vivo in individuals experiencing leprosy Type 1 reactions. The data support the possibility of an important role for TLR2 and TLR4 in the pathogenesis of this important complication of leprosy.


Asunto(s)
Glucocorticoides/uso terapéutico , Lepra/tratamiento farmacológico , Receptor Toll-Like 2/fisiología , Receptor Toll-Like 4/fisiología , Adolescente , Adulto , Análisis de Varianza , Antibióticos Antituberculosos/uso terapéutico , ADN Complementario/biosíntesis , Quimioterapia Combinada , Femenino , Expresión Génica , Humanos , Inmunohistoquímica , Lepra/genética , Lepra/mortalidad , Masculino , Metilprednisolona/uso terapéutico , Persona de Mediana Edad , Prednisolona/uso terapéutico , Receptor Toll-Like 2/efectos de los fármacos , Receptor Toll-Like 2/genética , Receptor Toll-Like 2/metabolismo , Receptor Toll-Like 4/efectos de los fármacos , Receptor Toll-Like 4/genética , Receptor Toll-Like 4/metabolismo , Adulto Joven
2.
Indoor Air ; 19(4): 303-13, 2009 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19500174

RESUMEN

UNLABELLED: For many people, a relatively large proportion of daily exposure to a multitude of pollutants may occur inside an automobile. A key determinant of exposure is the amount of outdoor air entering the cabin (i.e. air change or flow rate). We have quantified this parameter in six passenger vehicles ranging in age from 18 years to <1 year, at three vehicle speeds and under four different ventilation settings. Average infiltration into the cabin with all operable air entry pathways closed was between 1 and 33.1 air changes per hour (ACH) at a vehicle speed of 60 km/h, and between 2.6 and 47.3 ACH at 110 km/h, with these results representing the most (2005 Volkswagen Golf) and least air-tight (1989 Mazda 121) vehicles, respectively. Average infiltration into stationary vehicles parked outdoors varied between approximately 0 and 1.4 ACH and was moderately related to wind speed. Measurements were also performed under an air recirculation setting with low fan speed, while airflow rate measurements were conducted under two non-recirculate ventilation settings with low and high fan speeds. The windows were closed in all cases, and over 200 measurements were performed. The results can be applied to estimate pollutant exposure inside vehicles. PRACTICAL IMPLICATIONS: There is increasing recognition of the often disproportionately large contribution of in-vehicle pollutant exposures to overall measures. This has highlighted the need for accurate and representative quantification of determinant factors to facilitate exposure estimation and mitigation. The ventilation rate in a vehicle cabin is a key parameter affecting the transfer of pollutants from outdoors to the cabin interior, and vice-versa. New data regarding this variable are presented here, and the results indicate substantial variability in outdoor air infiltration into vehicles of differing age. The efficacy of simple measures to reduce outdoor air infiltration into 'leaky' vehicles to increase occupant protection would be a worthwhile avenue of further research.


Asunto(s)
Movimientos del Aire , Contaminación del Aire Interior/análisis , Automóviles , Contaminantes Atmosféricos , Australia , Ventilación
3.
Infect Immun ; 67(10): 5223-30, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10496899

RESUMEN

Gamma interferon (IFN-gamma)-secreting CD4+ T cells have long been established as an essential component of the protective immune response against Mycobacterium tuberculosis. It is now becoming evident from studies with the murine model of tuberculosis that an important role also exists for major histocompatibility complex (MHC) class I-restricted CD8+ T cells. These cells are capable of acting as both IFN-gamma secretors and cytotoxic T lymphocyte (CTL) effectors; however, their exact role in immunity against tuberculosis remains unclear. This study demonstrates the presence of Mycobacterium bovis BCG-reactive CD8+ T cells in healthy BCG-vaccinated donors and that these CD8+ T cells are potent cytokine producers as well as cytotoxic effector cells. Using FACScan analysis, we have shown that restimulation with live M. bovis BCG induced more CD8+-T-cell activation than the soluble antigen purified protein derivative and that these cells are actively producing the type 1 cytokines IFN-gamma and tumor necrosis factor alpha (TNF-alpha). These CD8+ T cells also contain the cytolytic granule perforin and are capable of acting as potent CTLs against M. bovis BCG-infected macrophages. The mycobacterial antigens 85A and B (Ag85A and Ag85B, respectively), and to a lesser extent the 19- and 38-kDa proteins, are major antigenic targets for these mycobacterium-specific CD8+ T cells, while whole-M. bovis BCG activated effector cells from these BCG-vaccinated donors, as expected, failed to recognize the 6-kDa ESAT-6 protein. The use of metabolic inhibitors and blocking antibodies revealed that the CD8+ T cells recognize antigen processed and presented via the classical MHC class I pathway. These data suggest that CD8+ T cells may play a critical role in the human immune response to tuberculosis infection.


Asunto(s)
Vacuna BCG/inmunología , Linfocitos T Citotóxicos/inmunología , Tuberculosis/inmunología , Presentación de Antígeno , Antígenos de Histocompatibilidad Clase I/fisiología , Humanos , Interferón gamma/biosíntesis , Factor de Necrosis Tumoral alfa/biosíntesis
4.
J Med Genet ; 33(8): 672-7, 1996 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-8863160

RESUMEN

The macrophage resistance gene NRAMP1 regulates priming/activation of macrophages for enhanced TNF alpha, IL 1 beta, and MHC class II expression. Since all of these functions are of potential importance in the induction or maintenance or both of autoimmune disease, samples from the Arthritis and Rheumatism Council's repository of multicase rheumatoid arthritis families were typed for a dinucleotide repeat in the NRAMP1 promoter region and four other 2q34 (TNP1) or 2q35 (IL8R, VIL1, DES) marker genes. Identity by descent (IBD) sib pair analysis using a three locus haplotype NRAMP1-IL8RB-VIL1, or NRAMP1 alone, provided preliminary evidence (maximum lod score = 1.01, p = 0.024) for a gene in this region contributing to suceptibility to rheumatoid arthritis. Candidacy for NRAMP1 as the disease susceptibility gene was supported by a significant bias (p = 0.048) towards transmission of the NRAMP1 promoter region allele 3 in affected offspring.


Asunto(s)
Artritis Reumatoide/genética , Proteínas Portadoras/genética , Proteínas de Transporte de Catión , Cromosomas Humanos Par 2/genética , Ligamiento Genético , Proteínas de la Membrana/genética , Repeticiones de Dinucleótido/genética , Genes/genética , Marcadores Genéticos/genética , Predisposición Genética a la Enfermedad , Haplotipos , Humanos , Funciones de Verosimilitud , Núcleo Familiar , Polimorfismo Genético , Polimorfismo de Longitud del Fragmento de Restricción , Regiones Promotoras Genéticas/genética
7.
Immunol Lett ; 30(2): 241-8, 1991 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-1757110

RESUMEN

This paper describes functional and genetic studies on the macrophage resistance gene Lsh/Ity/Bcg first described almost two decades ago. Working in vitro with resident peritoneal, liver (Kupffer cells) and bone marrow derived macrophages from congenic B10 (LshS) and B10.L-LshR mice it has been possible to demonstrate that the final effector mechanism for the gene in regulating antileishmanial activity involves production of reactive nitrogen rather than reactive oxygen intermediates. This in turn is dependent upon priming/activation of macrophages for enhanced TNF-alpha release which acts back on the macrophage in an autocrine manner to increase nitric oxide production. The precise point at which Lsh acts to control macrophage priming/activation has not been identified, but studies of early response gene expression show differences in KC mRNA levels at 2 h after LPS stimulation, and in c-fos mRNA as early as 20 min after stimulation with PMA plus ionophore, in peritoneal macrophages from congenic LshS and LshR mice. Data available suggest that both negative and positive signals may be involved in macrophage priming/activation, with LshS macrophages down-regulating their capacity for continued response to the autocrine loop. Work in progress will examine the role of TPA and cAMP response element-binding proteins in regulating gene expression in Lsh congenic mice. A major new initiative has also commenced to clone the Lsh gene by reverse genetics using yeast artificial chromosomes to walk towards Lsh from the closet proximal and distal markers on mouse chromosome 1.(ABSTRACT TRUNCATED AT 250 WORDS)


Asunto(s)
Regulación de la Expresión Génica/inmunología , Leishmania/genética , Activación de Macrófagos/genética , Macrófagos/inmunología , Animales , Humanos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...